140 related articles for article (PubMed ID: 20966540)
1. ESR1 amplification is rare in breast cancer and is associated with high grade and high proliferation: a multiplex ligation-dependent probe amplification study.
Moelans CB; Monsuur HN; de Pinth JH; Radersma RD; de Weger RA; van Diest PJ
Anal Cell Pathol (Amst); 2010; 33(1):13-8. PubMed ID: 20966540
[TBL] [Abstract][Full Text] [Related]
2. ESR1 amplification is rare in breast cancer and is associated with high grade and high proliferation: a multiplex ligation-dependent probe amplification study.
Moelans CB; Monsuur HN; de Pinth JH; Radersma RD; de Weger RA; van Diest PJ
Cell Oncol (Dordr); 2011 Oct; 34(5):489-94. PubMed ID: 21541733
[TBL] [Abstract][Full Text] [Related]
3. Detection of Gene Amplification by Multiplex Ligation-Dependent Probe Amplification in Comparison with In Situ Hybridization and Immunohistochemistry.
Tabarestani S; Ghaderian SM; Rezvani H
Asian Pac J Cancer Prev; 2015; 16(17):7997-8002. PubMed ID: 26625832
[TBL] [Abstract][Full Text] [Related]
4. Gene amplification of ESR1 in breast cancers--fact or fiction? A fluorescence in situ hybridization and multiplex ligation-dependent probe amplification study.
Ooi A; Inokuchi M; Harada S; Inazawa J; Tajiri R; Kitamura SS; Ikeda H; Kawashima H; Dobashi Y
J Pathol; 2012 May; 227(1):8-16. PubMed ID: 22170254
[TBL] [Abstract][Full Text] [Related]
5. ESR1 amplification in breast cancer by optimized RNase FISH: frequent but low-level and heterogeneous.
Moelans CB; Holst F; Hellwinkel O; Simon R; van Diest PJ
PLoS One; 2013; 8(12):e84189. PubMed ID: 24367641
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of ESR1 gene amplification, mRNA/protein expression and functional profiles in high-risk early breast cancer: a translational study of the Hellenic Cooperative Oncology Group (HeCOG).
Pentheroudakis G; Kotoula V; Eleftheraki AG; Tsolaki E; Wirtz RM; Kalogeras KT; Batistatou A; Bobos M; Dimopoulos MA; Timotheadou E; Gogas H; Christodoulou C; Papadopoulou K; Efstratiou I; Scopa CD; Papaspyrou I; Vlachodimitropoulos D; Linardou H; Samantas E; Pectasides D; Pavlidis N; Fountzilas G
PLoS One; 2013; 8(7):e70634. PubMed ID: 23923010
[TBL] [Abstract][Full Text] [Related]
7. Absence of estrogen receptor alpha (ESR1) gene amplification in a series of breast cancers in Taiwan.
Chen JR; Hsieh TY; Chen HY; Yeh KY; Chen KS; ChangChien YC; Pintye M; Chang LC; Hwang CC; Chien HP; Hsu YC
Virchows Arch; 2014 Jun; 464(6):689-99. PubMed ID: 24756215
[TBL] [Abstract][Full Text] [Related]
8. Breast carcinomas with low amplified/equivocal HER2 by Ish: potential supporting role of multiplex ligation-dependent probe amplification.
Ercolani C; Marchiò C; Di Benedetto A; Fabi A; Perracchio L; Vici P; Sperati F; Buglioni S; Arena V; Pescarmona E; Sapino A; Terrenato I; Mottolese M
J Exp Clin Cancer Res; 2017 Oct; 36(1):143. PubMed ID: 29029640
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor alpha gene ESR1 amplification may predict endocrine therapy responsiveness in breast cancer patients.
Tomita S; Zhang Z; Nakano M; Ibusuki M; Kawazoe T; Yamamoto Y; Iwase H
Cancer Sci; 2009 Jun; 100(6):1012-7. PubMed ID: 19320640
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of ESR1 gene copy number changes in breast cancer as measured by fluorescence in situ hybridisation.
Lin CH; Liu JM; Lu YS; Lan C; Lee WC; Kuo KT; Wang CC; Chang DY; Huang CS; Cheng AL
J Clin Pathol; 2013 Feb; 66(2):140-5. PubMed ID: 23268322
[TBL] [Abstract][Full Text] [Related]
11. Detection of HER2 amplification in breast carcinomas: comparison of Multiplex Ligation-dependent Probe Amplification (MLPA) and Fluorescence In Situ Hybridization (FISH) combined with automated spot counting.
Moerland E; van Hezik RL; van der Aa TC; van Beek MW; van den Brule AJ
Cell Oncol; 2006; 28(4):151-9. PubMed ID: 16988470
[TBL] [Abstract][Full Text] [Related]
12. Estrogen Receptor Alpha Gene Amplification Is an Independent Predictor of Long-Term Outcome in Postmenopausal Patients with Endocrine-Responsive Early Breast Cancer.
Singer CF; ; Holst F; Steurer S; Burandt EC; Lax SF; Jakesz R; Rudas M; Stöger H; Greil R; ; Sauter G; Filipits M; ; Simon R; Gnant M;
Clin Cancer Res; 2022 Sep; 28(18):4112-4120. PubMed ID: 35920686
[TBL] [Abstract][Full Text] [Related]
13. HER-2/neu amplification testing in breast cancer by multiplex ligation-dependent probe amplification in comparison with immunohistochemistry and in situ hybridization.
Moelans CB; de Weger RA; van Blokland MT; Ezendam C; Elshof S; Tilanus MG; van Diest PJ
Cell Oncol; 2009; 31(1):1-10. PubMed ID: 19096145
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer.
Holst F; Stahl PR; Ruiz C; Hellwinkel O; Jehan Z; Wendland M; Lebeau A; Terracciano L; Al-Kuraya K; Jänicke F; Sauter G; Simon R
Nat Genet; 2007 May; 39(5):655-60. PubMed ID: 17417639
[TBL] [Abstract][Full Text] [Related]
15. Molecular profiling of invasive breast cancer by multiplex ligation-dependent probe amplification-based copy number analysis of tumor suppressor and oncogenes.
Moelans CB; de Weger RA; Monsuur HN; Vijzelaar R; van Diest PJ
Mod Pathol; 2010 Jul; 23(7):1029-39. PubMed ID: 20473280
[TBL] [Abstract][Full Text] [Related]
16. Detection of HER2 and Topo 2 in breast cancers: comparison between MLPA and FISH approaches.
Bravaccini S; Rengucci C; Medri L; Zoli W; Silvestrini R; Amadori D
J Clin Pathol; 2012 Feb; 65(2):183-5. PubMed ID: 22039286
[TBL] [Abstract][Full Text] [Related]
17. HER-2/neu amplification testing in breast cancer by Multiplex Ligation-dependent Probe Amplification: influence of manual- and laser microdissection.
Moelans CB; de Weger RA; Ezendam C; van Diest PJ
BMC Cancer; 2009 Jan; 9():4. PubMed ID: 19123950
[TBL] [Abstract][Full Text] [Related]
18. Oestrogen receptor gene (ESR1) amplification is frequent in endometrial carcinoma and its precursor lesions.
Lebeau A; Grob T; Holst F; Seyedi-Fazlollahi N; Moch H; Terracciano L; Turzynski A; Choschzick M; Sauter G; Simon R
J Pathol; 2008 Oct; 216(2):151-7. PubMed ID: 18720455
[TBL] [Abstract][Full Text] [Related]
19. ESR1 gene status correlates with estrogen receptor protein levels measured by ligand binding assay and immunohistochemistry.
Laenkholm AV; Knoop A; Ejlertsen B; Rudbeck T; Jensen MB; Müller S; Lykkesfeldt AE; Rasmussen BB; Nielsen KV
Mol Oncol; 2012 Aug; 6(4):428-36. PubMed ID: 22626971
[TBL] [Abstract][Full Text] [Related]
20. Absence of chromosome 17 polysomy in breast cancer: analysis by CEP17 chromogenic in situ hybridization and multiplex ligation-dependent probe amplification.
Moelans CB; de Weger RA; van Diest PJ
Breast Cancer Res Treat; 2010 Feb; 120(1):1-7. PubMed ID: 19760503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
